evinacumab
General
Pronunciation:
e-vin-ak-ue-mab
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Evkeeza
Ther. Class.
lipid-lowering agents
Pharm. Class.
angiopoietin-like 3 (ANGPTL3) inhibitors
monoclonal antibodies
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Evinacumab." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. Harriet Lane, www.unboundmedicine.com/harrietlane/view/Davis-Drug-Guide/3580147/0/evinacumab.
Vallerand AHA, Sanoski CAC. Evinacumab. Davis's Drug Guide. F.A. Davis Company; 2026. https://www.unboundmedicine.com/harrietlane/view/Davis-Drug-Guide/3580147/0/evinacumab. Accessed July 2, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Evinacumab. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://www.unboundmedicine.com/harrietlane/view/Davis-Drug-Guide/3580147/0/evinacumab
Vallerand AHA, Sanoski CAC. Evinacumab [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 July 02]. Available from: https://www.unboundmedicine.com/harrietlane/view/Davis-Drug-Guide/3580147/0/evinacumab.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - evinacumab
ID - 3580147
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://www.unboundmedicine.com/harrietlane/view/Davis-Drug-Guide/3580147/0/evinacumab
PB - F.A. Davis Company
ET - 20
DB - Harriet Lane
DP - Unbound Medicine
ER -

Davis's Drug Guide

